As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...